APA-Zitierstil (7. Ausg.)

Engeland, C. E. (2022). Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine. Molecular therapy. Methods & clinical development, 27, . https://doi.org/10.1016/j.omtm.2022.09.003

Chicago-Zitierstil (17. Ausg.)

Engeland, Christine Elisabeth. "Safety Study Supports Clinical Development of Immunotherapeutic Oncolytic Measles Vaccine." Molecular Therapy. Methods & Clinical Development 27 (2022). https://doi.org/10.1016/j.omtm.2022.09.003.

MLA-Zitierstil (9. Ausg.)

Engeland, Christine Elisabeth. "Safety Study Supports Clinical Development of Immunotherapeutic Oncolytic Measles Vaccine." Molecular Therapy. Methods & Clinical Development, vol. 27, 2022, https://doi.org/10.1016/j.omtm.2022.09.003.